Abbott Laboratories Share Price NEO Exchange
Stocks
ABT
CA0028221046
Medical Equipment, Supplies & Distribution
| Market Cap | 19TCr 16TCr 15TCr 14TCr 26TCr 17,69800Cr 26TCr 1,79300Cr 70TCr 9,08100Cr 70TCr 69TCr 29,25300Cr | P/E 2026 * |
31.1x | P/E 2027 * | 23.9x |
|---|---|---|---|---|---|
| Enterprise Value | 21TCr 18TCr 17TCr 16TCr 29TCr 19,95900Cr 29TCr 2,02200Cr 78TCr 10,24000Cr 79TCr 78TCr 32,98900Cr | EV / Sales 2026 * |
4.2x | EV / Sales 2027 * | 3.81x |
| Free-Float |
86.16% | Yield 2026 * |
2.37% | Yield 2027 * | 2.53% |
Last Transcript : Abbott Laboratories
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 19TCr | |
| -0.42% | -3.68% | -18.51% | +7.39% | 19TCr | |
| +1.15% | +3.22% | +1.37% | +17.42% | 12TCr | |
| -1.86% | +2.77% | +13.15% | +91.44% | 6.32TCr | |
| -1.31% | -1.09% | +17.67% | +43.65% | 5.17TCr | |
| -1.54% | -2.52% | -3.98% | -32.30% | 5.03TCr | |
| -2.02% | -3.22% | +9.18% | -12.39% | 3.32TCr | |
| 0.00% | +3.71% | - | - | 3.21TCr | |
| -0.81% | +0.74% | +35.59% | -15.78% | 2.39TCr | |
| -1.44% | -4.21% | -8.07% | +11.30% | 2.3TCr | |
| Average | -0.82% | -0.07% | +5.80% | +13.84% | 6.5TCr | |
| Weighted average by Cap. | -0.42% | +0.02% | -1.43% | +16.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.03TCr 4.33TCr 4.07TCr 3.72TCr 6.96TCr 4,74900Cr 6.98TCr 48TCr 19TCr 2,43700Cr 19TCr 18TCr 7,85000Cr | 5.46TCr 4.7TCr 4.42TCr 4.04TCr 7.56TCr 5,15900Cr 7.58TCr 52TCr 20TCr 2,64700Cr 21TCr 20TCr 8,52800Cr |
| Net income | 623.24Cr 536.29Cr 504.58Cr 460.93Cr 862.27Cr 59TCr 864.62Cr 5.96TCr 2.31TCr 30TCr 2.34TCr 2.29TCr 97TCr | 792.44Cr 681.9Cr 641.57Cr 586.07Cr 1.1TCr 75TCr 1.1TCr 7.58TCr 2.94TCr 38TCr 2.98TCr 2.91TCr 1,23700Cr |
| Net Debt | 2.39TCr 2.06TCr 1.94TCr 1.77TCr 3.31TCr 2,26000Cr 3.32TCr 23TCr 8.89TCr 1,16000Cr 8.99TCr 8.79TCr 3,73600Cr | 2.1TCr 1.8TCr 1.7TCr 1.55TCr 2.9TCr 1,97900Cr 2.91TCr 20TCr 7.78TCr 1,01500Cr 7.87TCr 7.7TCr 3,27100Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
